000			02068 a2200601 4500
005			20250515095122.0
264		0	_c20080415
008			200804s 0 0 eng d
022			_a0006-4971
024	7		_a10.1182/blood-2007-07-104281 _2doi
040			_aNLM _beng _cNLM
100	1		_aFitter, Stephen
245	0	0	_aLong-term imatinib therapy promotes bone formation in CML patients. _h[electronic resource]
260			_bBlood _cMar 2008
300			_a2538-47 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdipogenesis _xdrug effects
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBenzamides
650	0	4	_aCalcification, Physiologic _xdrug effects
650	0	4	_aCalcium _xblood
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Leukemic _xdrug effects
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy
650	0	4	_aMale
650	0	4	_aMesenchymal Stem Cells _xdrug effects
650	0	4	_aMiddle Aged
650	0	4	_aOrgan Size _xdrug effects
650	0	4	_aOsteogenesis _xdrug effects
650	0	4	_aPhosphates _xblood
650	0	4	_aPiperazines _xpharmacology
650	0	4	_aPlatelet-Derived Growth Factor _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-crk _xmetabolism
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aTime Factors
700	1		_aDewar, Andrea L
700	1		_aKostakis, Panagiota
700	1		_aTo, L Bik
700	1		_aHughes, Timothy P
700	1		_aRoberts, Marion M
700	1		_aLynch, Kevin
700	1		_aVernon-Roberts, Barrie
700	1		_aZannettino, Andrew C W
773	0		_tBlood _gvol. 111 _gno. 5 _gp. 2538-47
856	4	0	_uhttps://doi.org/10.1182/blood-2007-07-104281 _zAvailable from publisher's website
999			_c17557792 _d17557792